Where are we with the vaccination once morest Covid-19? What do we know regarding the best-covered audiences? Who is affected by the second booster dose? La Dépêche takes stock.
France has 92.1% of fully vaccinated adults, according to the last numbers published by the health authorities. As of Friday August 26, this represents 53,645,539 French people.
Since the start of the Covid-19 pandemic, nearly 190 million doses of vaccine have been distributed. As of August 23, 59.8% of the population has received a full primary vaccination and a booster dose. Conversely, 19.6% of French people have not yet received any dose.
79% of French people have received a complete primary vaccination, according to the latest reports.
Since the start of the epidemic, France has experienced two major waves of vaccination: a first during the summer of 2021, and a second at the end of 2021-beginning of 2022. Brittany is the best vaccinated region, with 66.1% of people with a complete vaccination schedule as well as at least one booster dose.
Note that the giant Pfizer-BioNTech remains the big winner of vaccination in France. According to Santé Publique France, 85.7% of first-time vaccinators received the serum from the American-German firm.
The second booster dose shunned
Among those over 65, 94.5% received at least one dose. However, “the vaccination effort must be increased to improve the vaccination coverage which remains insufficient, especially in the overseas territories and among the elderly”, advocated Public Health France at the beginning of August.
Because vaccination seems to be stuck at the level of the second booster dose, extended to new audiences since July 20, 2022. “On August 1, only 32.6% of 60-79 year olds, 43.5% of 80 year olds and more, as well as 48.2% of nursing home residents had received their second booster dose”, alerted the health organization.
As a reminder, several categories of people are affected by this new dose:
- Immunocompromised people
- People aged 80 and over as well as all residents of EHPADs and USLDs (long-term care units) who have received their booster dose for more than three months.
- Adults aged 18 to 60 identified as being at risk of severe form of Covid-19
- Pregnant women from the first trimester of pregnancy
- People living in the vicinity or in regular contact with vulnerable people
- The nursing staff
